ChoA Pharmaceutical Co.Ltd (034940) — Cash Flow Reinvestment Rate
ChoA Pharmaceutical Co.Ltd (034940) has a Cash Flow Reinvestment Rate of 2.22x as of September 2025, reinvesting ₩2.80 Billion (capex ₩324.67 Million plus investments ₩-2.48 Billion) from operating cash flow of ₩1.26 Billion. See 034940 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ChoA Pharmaceutical Co.Ltd Cash Flow Reinvestment Rate (2004–2020)
Historical reinvestment intensity for ChoA Pharmaceutical Co.Ltd across 8 annual periods. For the full cash flow conversion analysis, see 034940 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for ChoA Pharmaceutical Co.Ltd (2004–2020)
Year-by-year capital reinvestment analysis for ChoA Pharmaceutical Co.Ltd. See how financially flexible is ChoA Pharmaceutical Co.Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.89x | ₩3.63 Billion | ₩1.92 Billion | ₩3.60 Billion | ▲ +248.0% |
| 2019 | 0.54x | ₩2.25 Billion | ₩4.16 Billion | ₩1.39 Billion | ▼ -62.6% |
| 2018 | 1.45x | ₩2.96 Billion | ₩2.04 Billion | ₩1.97 Billion | ▼ -56.1% |
| 2016 | 3.30x | ₩3.07 Billion | ₩930.42 Million | ₩2.30 Billion | ▲ +26.5% |
| 2015 | 2.61x | ₩3.10 Billion | ₩1.19 Billion | ₩1.78 Billion | ▼ -72.7% |
| 2014 | 9.55x | ₩5.97 Billion | ₩625.52 Million | ₩5.64 Billion | ▲ +3059.9% |
| 2013 | 0.30x | ₩1.07 Billion | ₩3.53 Billion | ₩1.07 Billion | ▲ +110.8% |
| 2004 | 0.14x | ₩512.47 Million | ₩3.57 Billion | ₩512.47 Million | — |